David Sykes
- QAW039, a slowly dissociating CRTh2 antagonist with potential for improved clinical efficacyBy David Sykes, Michelle Bradley, Darren Riddy, Liz Willard, Ellen Powell-Herlaar, Dave Sandham, Simon Watson, Carsten Bauer, Gerald Dubois and Steven CharltonDavid Sykes1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomMichelle Bradley1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomDarren Riddy1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomLiz Willard1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomEllen Powell-Herlaar1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomDave Sandham1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomSimon Watson1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomCarsten Bauer2Isotopes Labs, Novartis Institutes for BioMedical Research, Basel, SwitzerlandGerald Dubois1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomSteven Charlton1Primary Care, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.